<?xml version="1.0" encoding="UTF-8"?>
<results title="test_trace">
 <result pre="cytotoxicity and antiviral activity. The cell viability was calculated by" exact="detection" post="of cellular ATP after treatment with various concentrations of"/>
 <result pre="cell viability was calculated by detection of cellular ATP after" exact="treatment" post="with various concentrations of NPRE. For antiviral studies, five"/>
 <result pre="0.4, 0.6, 0.8 mg/mL) were tested. Our study demonstrated that" exact="treatment" post="with NPRE (0.4, 0.6, 0.8 mg/mL) reduced the expression"/>
 <result pre="virus antiviral pistachios polyphenols 1. Introduction Herpes simplex virus (HSV)" exact="infection" post="is quite common in adults and neonates and is"/>
 <result pre="absence of treatment, the mortality rate associated with central HSV" exact="infection" post="is around 70% [1]. Furthermore, the virus persists in"/>
 <result pre="famciclovir, and ganciclovir, are widely used for the prophylaxis and" exact="treatment" post="of HSV infections [2]. These drugs are considered first-line"/>
 <result pre="than 40% of humans have recurrent infections, and repeated pharmacological" exact="treatment" post="often results in the development of drug-resistant HSV strains"/>
 <result pre="pistachio kernels, we performed a first step of experiments by" exact="testing" post="polyphenol-rich fractions derived from natural raw shelled (NP). To"/>
 <result pre="h and the cell morphology was then observed. The preliminary" exact="screening" post="indicated that treatment with NPRE did not affect the"/>
 <result pre="cell morphology was then observed. The preliminary screening indicated that" exact="treatment" post="with NPRE did not affect the growth of cell"/>
 <result pre="totally reduced (100%) as obtained with 20 µM of acyclovir" exact="treatment" post="(positive control) (Figure 2). The half-maximal effective concentration (EC50)"/>
 <result pre="were uninfected (mock) or infected with HSV-1 at multiplicity of" exact="infection" post="(MOI) 1 and treated or untreated with 0.6 and"/>
 <result pre="compared to the untreated infected samples, suggesting that the NPRE" exact="treatment" post="might have interfered with the DNA synthesis process, and"/>
 <result pre="of inhibition of viral replication. The previous data showed that" exact="treatment" post="with 0.8 mg/mL of NPRE extract resulted in a"/>
 <result pre="viral DNA and protein accumulation, compared to the control. Furthermore," exact="treatment" post="with NPRE extracts at the same concentration showed good"/>
 <result pre="h at 4 °C with the NPRE (0.8 mg/mL). The" exact="infection" post="was conducted at 4 °C, allowing the virus to"/>
 <result pre="the cell. The results from the assay showed that the" exact="treatment" post="with NPRE had no effect on the initial attachment"/>
 <result pre="binding assay using VP26-HSV-1 virus. Figure 5 shows that the" exact="treatment" post="with NP MIX resulted in a 50% decrease of"/>
 <result pre="herpes viruses have become a potential risk factor for HIV" exact="infection" post="in humans, and there is an increased need to"/>
 <result pre="from Vero cells infected with HSV-1 at low multiplicity of" exact="infection" post="(MOI) and harvested at 24 h post infection (p.i.)."/>
 <result pre="multiplicity of infection (MOI) and harvested at 24 h post" exact="infection" post="(p.i.). The cell-free supernatant containing the viral suspension was"/>
 <result pre="were then infected with the virus inoculum at multiplicity of" exact="infection" post="(MOI) of 1, and the infection was performed at"/>
 <result pre="inoculum at multiplicity of infection (MOI) of 1, and the" exact="infection" post="was performed at 4 °C with gentle shaking for"/>
 <result pre="and fresh media was then added. After 24 h post" exact="infection" post="(p.i.), the expression of the VP26 GFP protein was"/>
 <result pre="expression of the VP26 GFP protein was detected by (i)" exact="detection" post="of the auto-fluorescence of VP26-tagged protein and (ii) Western"/>
 <result pre="development of novel topical or oral drug formulations for the" exact="treatment" post="of HSV-1 infections, either alone or in combination with"/>
 <result pre="amongst other natural products, pistachio extracts could provide a novel" exact="treatment" post="against HSV-1 infections, as well as a novel strategy"/>
 <result pre="simplex virus type 1 as a cause of genital herpes" exact="infection" post="in college studentsSex Transm. Dis.20033079780010.1097/01.OLQ.0000092387.58746.C714520181 23.KhanM.T.H.AtherA.ThompsonK.D.GambariR.Extracts and molecules from"/>
 <result pre="and 0.01, respectively. Figure 5 Effect of the NP MIX" exact="treatment" post="on HSV-1 replication. Vero cells were either infected or"/>
 <result pre="GFP (green fluorescent protein-tagged capsid protein VP26) at multiplicity of" exact="infection" post="(MOI) 1, as described in the Materials and Methods"/>
 <result pre="section. Then, the cells were analysed at 24 h post" exact="infection" post="(p.i.): (a) fluorescent images showed the green dots representing"/>
</results>
